Specific criteria, including the rate of growth, grade, and Ki-67 expression, should be used to guide risk of over-treatment with nonessential resection and the potential complications, against the risk of under-treatment and potential to cure a less aggressive tumor. The gene discussed is MKI67; the disease is neoplasm.